Galectin Therapeutics Shares Extend Losses Into Third Session

Galectin Therapeutics US3632252025

Shares of Galectin Therapeutics declined for a third consecutive trading day on Tuesday, closing at $5.46. The session’s loss amounted to 0.91%. During the day’s trading, the stock price fluctuated within a 5.84% range, hitting an intraday low of $5.31 and a high of $5.62. Over the past ten trading sessions, the equity has finished lower in five of them, resulting in a cumulative decline of 9%.

A notable development accompanying the price drop was a significant surge in trading activity. Volume increased by 71,000 shares to a total of 297,000 shares traded, representing a monetary value of approximately $1.62 million. This rise in volume amid falling prices is often viewed by market participants as an indicator of heightened selling pressure.